🇺🇸 FDA
Patent

US 7335662

Substituted tricyclic compounds as protein kinase inhibitors

granted A61PA61P35/00A61P35/04

Quick answer

US patent 7335662 (Substituted tricyclic compounds as protein kinase inhibitors) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P35/00, A61P35/04, A61P43/00